Genome-wide association study in Estonia reveals importance of vaginal epithelium associated genes in case of recurrent vaginitis.

[1]  R. Mändar,et al.  Impact of Lactobacillus crispatus-containing oral and vaginal probiotics on vaginal health: a randomised double-blind placebo controlled clinical trial. , 2023, Beneficial microbes.

[2]  Wei-Qi Wei,et al.  Genome-wide association analyses of common infections in a large practice-based biobank , 2022, BMC Genomics.

[3]  R. Mägi,et al.  Advancing our understanding of genetic risk factors and potential personalized strategies for pelvic organ prolapse , 2022, Nature Communications.

[4]  Petra M. Casey,et al.  Evaluation and Management of Vaginitis. , 2022, Mayo Clinic proceedings.

[5]  A. Hu,et al.  Association between Human Genetic Variants and the Vaginal Bacteriome of Pregnant Women , 2021, mSystems.

[6]  T. Hawn,et al.  Genetic Variation in Toll-Like Receptor 5 and Colonization with Flagellated Bacterial Vaginosis-Associated Bacteria , 2020, Infection and Immunity.

[7]  J. Ravel,et al.  Bacterial Vaginosis and Its Association with Infertility, Endometritis, and Pelvic Inflammatory Disease. , 2020, American journal of obstetrics and gynecology.

[8]  L. Hou,et al.  Host Genetic Factors Associated with Vaginal Microbiome Composition in Kenyan Women , 2020, mSystems.

[9]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[10]  J. H. van de Wijgert,et al.  Intermittent Lactobacilli-containing Vaginal Probiotic or Metronidazole Use to Prevent Bacterial Vaginosis Recurrence: A Pilot Study Incorporating Microscopy and Sequencing , 2020, Scientific Reports.

[11]  M. Kordowska-Wiater,et al.  Microbiome Of The Women’S Genital System , 2019, Postępy Mikrobiologii - Advancements of Microbiology.

[12]  R. Mägi,et al.  Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records , 2018, European Journal of Human Genetics.

[13]  Judith A. Blake,et al.  Mouse Genome Database (MGD) 2019 , 2018, Nucleic Acids Res..

[14]  R. Mägi,et al.  Large-scale meta-analysis highlights the hypothalamic–pituitary–gonadal axis in the genetic regulation of menstrual cycle length , 2018, Human molecular genetics.

[15]  R. Ness,et al.  Toll‐like receptor variants and cervical Atopobium vaginae infection in women with pelvic inflammatory disease , 2018, American journal of reproductive immunology.

[16]  Erdogan Taskesen,et al.  Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.

[17]  J. Caeiro,et al.  Contribution of TLR2 pathway in the pathogenesis of vulvovaginal candidiasis. , 2017, Pathogens and disease.

[18]  Jin Wook Kim,et al.  Distinct Histone Modifications Modulate DEFB1 Expression in Human Vaginal Keratinocytes in Response to Lactobacillus spp. , 2017, Probiotics and Antimicrobial Proteins.

[19]  R. Mägi,et al.  Improved imputation accuracy of rare and low-frequency variants using population-specific high-coverage WGS-based imputation reference panel , 2017, European Journal of Human Genetics.

[20]  Namarta Kalia,et al.  Genetic and Phenotypic Screening of Mannose-Binding Lectin in Relation to Risk of Recurrent Vulvovaginal Infections in Women of North India: A Prospective Cohort Study , 2017, Front. Microbiol..

[21]  N. Eriksson,et al.  Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections , 2016, Nature Communications.

[22]  M. Jaeger,et al.  Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVC , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[23]  R. Fichorova,et al.  The Human Microbiome during Bacterial Vaginosis , 2016, Clinical Microbiology Reviews.

[24]  Po-Ru Loh,et al.  Fast and accurate long-range phasing in a UK Biobank cohort , 2015, Nature Genetics.

[25]  J. Wastling,et al.  Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier , 2015, Mucosal Immunology.

[26]  A. Bigham,et al.  Toll-like receptor gene variants and bacterial vaginosis among HIV-1 infected and uninfected African women , 2015, Genes and Immunity.

[27]  Joris M. Mooij,et al.  MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..

[28]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[29]  S. Boccia,et al.  Mannose-Binding Lectin Codon 54 Gene Polymorphism and Vulvovaginal Candidiasis: A Systematic Review and Meta-Analysis , 2014, BioMed research international.

[30]  E. Mylonakis,et al.  The Role of TLR4 896 A>G and 1196 C>T in Susceptibility to Infections: A Review and Meta-Analysis of Genetic Association Studies , 2013, PloS one.

[31]  P. De Sutter,et al.  Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis. , 2013, Human reproduction.

[32]  S. Shrestha,et al.  Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents. , 2012, Journal of reproductive immunology.

[33]  B. Browning,et al.  A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. , 2009, American journal of human genetics.

[34]  M. Krohn,et al.  Predicting risk of bacterial vaginosis: the role of race, smoking and corticotropin-releasing hormone-related genes. , 2009, Molecular human reproduction.

[35]  L. Meyn,et al.  A Delicate Balance: Risk Factors for Acquisition of Bacterial Vaginosis Include Sexual Activity, Absence of Hydrogen Peroxide-Producing Lactobacilli, Black Race, and Positive Herpes Simplex Virus Type 2 Serology , 2008, Sexually transmitted diseases.

[36]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[37]  W. Ledger,et al.  Mannose-Binding Lectin Gene Polymorphism, Vulvovaginal Candidiasis, and Bacterial Vaginosis , 2007, Obstetrics and gynecology.

[38]  G. Spear,et al.  Bacterial vaginosis and host immunity , 2007, Current HIV/AIDS reports.

[39]  Scott M. Williams,et al.  Association of interleukin-1β and interleukin-1 receptor antagonist polymorphisms with bacterial vaginosis in non-pregnant Italian women , 2007 .

[40]  M. Klebanoff,et al.  Differences in inflammatory cytokine and Toll-like receptor genes and bacterial vaginosis in pregnancy. , 2005, American journal of obstetrics and gynecology.

[41]  E. Norwitz,et al.  Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. , 2004, European journal of obstetrics, gynecology, and reproductive biology.

[42]  R. Fichorova,et al.  Response to Neisseria gonorrhoeae by Cervicovaginal Epithelial Cells Occurs in the Absence of Toll-Like Receptor 4-Mediated Signaling1 , 2002, The Journal of Immunology.

[43]  C. Mehlin,et al.  Lactobacilli and vaginal host defense: activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-kappaB. , 1999, The Journal of infectious diseases.

[44]  A. Landay,et al.  A Human Immunodeficiency Virus (HIV)-Inducing Factor from the Female Genital Tract Activates HIV-1 Gene Expression through the κB Enhancer , 1998 .

[45]  J. Sobel.  Recurrent vulvovaginal candidiasis. , 1987, American journal of obstetrics and gynecology.

[46]  OUP accepted manuscript , 2021, Human Reproduction.

[47]  R. Mägi,et al.  Cohort Profile Cohort Profile : Estonian Biobank of the Estonian Genome Center , University of Tartu , 2015 .

[48]  M. Vaneechoutte,et al.  Gene polymorphisms of Toll-like and related recognition receptors in relation to the vaginal carriage of Gardnerella vaginalis and Atopobium vaginae. , 2009, Journal of reproductive immunology.